Back to search
Neonatal Opiate Withdrawal Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Neonatal Opiate Withdrawal Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Neonatal Opiate Withdrawal Syndrome trials you may qualify forThe goal of this observational study is to learn how two medicines used in routine care-buprenorphine and morphine-affect recovery in newborns (≥36 weeks' gesta…
Infants with neonatal abstinence syndrome (NAS) experience prolonged hospital stays and poor neurodevelopmental outcomes, in-part because of the lack of accurat…
The objective of this study is to determine if tAN therapy can reduce the median number of days of oral morphine administered to an infant after start of treatm…
This is a sub-study of NIDA CTN Protocol 0080: Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs; Unique protocol ID: 2019-0429-1). Partic…